• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Crocs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    2/13/25 7:01:32 AM ET
    $CROX
    Shoe Manufacturing
    Consumer Discretionary
    Get the next $CROX alert in real time by email
    crox-20250213
    0001334036false00013340362025-02-132025-02-13

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): February 13, 2025
    CROCS, INC.
    (Exact name of registrant as specified in its charter)
    Delaware

    0-51754

    20-2164234
    (State or other jurisdiction

    (Commission File Number)

    (I.R.S. Employer
    of incorporation)
     

     
     

    Identification No.)



    500 Eldorado Blvd., Building 5

    Broomfield,
    Colorado
    80021
    (Address of principal executive offices)
     
     
    (Zip Code)
     
     Registrant’s telephone number, including area code: (303) 848-7000
     
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class:Trading symbol:Name of each exchange on which registered:
    Common Stock, par value $0.001 per shareCROXThe Nasdaq Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.45) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
        Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    1



    Item 2.02. Results of Operations and Financial Condition.
     
    On February 13, 2025, Crocs, Inc. (the “Company”) issued a press release reporting its results of operations for the three and twelve months ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this report.

    Item 8.01. Other Events.

    On February 13, 2025, the Company also announced that its Board of Directors (the “Board”) has increased the Company’s existing common stock repurchase authorization by $1.0 billion. Including this increase, approximately $1.3 billion remains available for repurchase under the Company’s common stock repurchase authorization as of the date of this Current Report on Form 8-K.

    The number, price, structure and timing of the repurchases, if any, will be at the Company’s sole discretion and future repurchases will be evaluated by the Company depending on market conditions, liquidity needs, restrictions under the Company’s debt arrangements, and other factors. Share repurchases may be made in the open market or in privately negotiated transactions. The repurchase authorization does not have an expiration date and does not oblige the Company to acquire any particular amount of the Company’s common stock. The Board may suspend, modify, or terminate the repurchase program at any time without prior notice.

    Item 9.01. Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit
    No.
     
     
     
    Description
     
    99.1

    Crocs, Inc. press release dated February 13, 2025.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
     
    CROCS, INC.
     
     
     
     
     
     
     
    Date: February 13, 2025
    By:
    /s/ Susan Healy
     
     
     
     
    Susan Healy
     
     
     
     
    Executive Vice President and Chief Financial Officer
     
     


    2
    Get the next $CROX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CROX

    DatePrice TargetRatingAnalyst
    3/12/2025$110.00Hold → Buy
    Loop Capital
    11/22/2024$116.00Buy
    Needham
    11/7/2024$150.00 → $110.00Buy → Hold
    Loop Capital
    10/30/2024$170.00 → $140.00Buy
    Monness Crespi & Hardt
    10/30/2024Outperform → Mkt Perform
    Raymond James
    10/9/2024$182.00Buy
    Guggenheim
    8/23/2024$170.00Overweight
    Piper Sandler
    8/2/2024$164.00Strong Buy → Outperform
    Raymond James
    More analyst ratings